1-234607214-G-T
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PP3_Moderate
The NM_182972.3(IRF2BP2):c.1687C>A(p.Pro563Thr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P563L) has been classified as Uncertain significance.
Frequency
Consequence
NM_182972.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IRF2BP2 | NM_182972.3 | c.1687C>A | p.Pro563Thr | missense_variant | 2/2 | ENST00000366609.4 | NP_892017.2 | |
IRF2BP2 | NM_001077397.1 | c.1639C>A | p.Pro547Thr | missense_variant | 2/2 | NP_001070865.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IRF2BP2 | ENST00000366609.4 | c.1687C>A | p.Pro563Thr | missense_variant | 2/2 | 1 | NM_182972.3 | ENSP00000355568.3 | ||
IRF2BP2 | ENST00000366610.7 | c.1639C>A | p.Pro547Thr | missense_variant | 2/2 | 1 | ENSP00000355569.3 | |||
ENSG00000228830 | ENST00000436039.1 | n.207G>T | non_coding_transcript_exon_variant | 1/2 | 3 | |||||
IRF2BP2 | ENST00000491430.1 | n.*17C>A | downstream_gene_variant | 1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2023 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. This variant has not been reported in the literature in individuals affected with IRF2BP2-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces proline, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 563 of the IRF2BP2 protein (p.Pro563Thr). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.